APA ציטוט

Kario, K., Tamaki, Y., Okino, N., Gotou, H., Zhu, M., & Zhang, J. (2015). LCZ696, a First‐in‐Class Angiotensin Receptor‐Neprilysin Inhibitor: The First Clinical Experience in Patients With Severe Hypertension. J Clin Hypertens (Greenwich).

Citação norma Chicago

Kario, Kazuomi, Yuko Tamaki, Naoko Okino, Hiromi Gotou, Min Zhu, and Jack Zhang. "LCZ696, a First‐in‐Class Angiotensin Receptor‐Neprilysin Inhibitor: The First Clinical Experience in Patients With Severe Hypertension." J Clin Hypertens (Greenwich) 2015.

ציטוט MLA

Kario, Kazuomi, et al. "LCZ696, a First‐in‐Class Angiotensin Receptor‐Neprilysin Inhibitor: The First Clinical Experience in Patients With Severe Hypertension." J Clin Hypertens (Greenwich) 2015.

אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.